The Chinese drugmakers and face mask-makers’ shares jumped on Monday morning after growing concerns over an outbreak of coronavirus spreading to many other cities in the country. Shenzhen Neptunus Bioengineering, Jiangsu Sihuan Bioengineering and Shandong Lukang Pharmaceutical all observe their stocks rise by around 10%, their movement limit on a daily basis. In the meantime, the shares of face mask manufacturers also got a lift, with Tianjin Teda mounting about 9% while Shanghai Dragon soared nearly 10%.
Reuters said that the stock moves came after Chinese authorities reported on Monday that 140 new cases of coronavirus discovered during the weekend. Three of the new cases confirmed outside the Wuhan, where the virus first reported. For its part, the National Health Commission of China said in a press release on Sunday that experts believed the current situation still controllable and preventable, according to CNBC’s translation of Chinese language text.
Faculty instructor at the Center for Global Health Science & Security at Georgetown University, Alexandra Phelan said what evident by the most recent data that come out instantaneous, that likely they have human-to-human transmission happening. Phelan tells CNBC that now they are starting to take a sense that possibly gives the scale they may have more continuous and more efficient person-to-person transmission – and that’s really what they are looking out for because that will tell them whether the disease is going to grow more quickly between people.
World Health Organization about Chinese Coronavirus
According to the World Health Organization (WHO), viruses like coronaviruses are a big family of viruses that may cause less-severe diseases like a common cold. Whereas others might lead to more dangerous such as the Severe Acute Respiratory Syndrome (SARS) and the Middle East respiratory syndrome. According to WHO statistics, the SARS spread-out in 2002 and 2003 resulted in about eight-hundred deaths, with the majority of the infected from China and Hong Kong.